Linda first joined Redoxis as a master’s student in 2014 and later returned to the company as an in vitro scientist after gaining experience from several roles within the life science industry.
At Redoxis, Linda contributes to the development and execution of in vitro studies, supporting a range of immunological assays and cellular experiments. Her broad technical background and structured approach help ensure efficient laboratory workflows and reliable data generation.
Her work supports Redoxis’ in vitro research platforms and contributes to the generation of robust preclinical data within inflammation and autoimmune disease.
